Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon.

The American journal of gastroenterology - 1 Jun 1998

Montalto G, Tripi S, Cartabellotta A, Fulco M, Soresi M, Di Gaetano G, Carroccio A, Levrero M

Abstract excerpt

OBJECTIVES: alpha-Interferons (alpha-IFN) have been shown to be effective in the treatment of chronic viral C hepatitis, but their efficacy remains unsatisfactory. Recently natural beta-interferon (beta-IFN) administered by intravenous infusion has been used successfully. METHODS: To evaluate the efficacy and safety of intravenous beta-IFN administration we treated 20 patients with histologically proven chronic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to Hepacivirus

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hepatitis C, Chronic

Share to Infusions, Intravenous

Share to Interferon-alpha

Share to Interferon-beta

Share to RNA, Viral

Share to Treatment Outcome

Source

Identifiers

PMID: 9647026
DOI: 10.1111/j.1572-0241.1998.00285.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Intravenous natural beta-interferon in white patients with chronic hepatitis C who are nonresponders to alpha-interferon.PMID 9647026Read ↗

Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.Semantic proximity Read ↗

Prospective study of a high-intensity interferon-alpha regimen for chronic hepatitis C virus genotype 1b infection.Semantic proximity Read ↗

Intravenous recombinant interferon-beta versus interferon-alpha-2b and ribavirin in combination for short-term treatment of chronic hepatitis C patients not responding to interferon-alpha. Multicenter Interferon Beta Italian Group Investigators.Semantic proximity Read ↗

Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients.Semantic proximity Read ↗

Comparison of biochemical safety between PEG-IFN alpha-2a and PEG-IFN alpha-2b.Semantic proximity Read ↗

Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.Semantic proximity Read ↗

Improved pharmacodynamics and pharmacokinetics after i.v. application of peginterferon alfa-2a in hepatitis C null responders.Semantic proximity Read ↗

Granulocyte colony stimulating factor in HCV genotype-1 patients who develop Peg-IFN-alpha2b related severe neutropenia: a preliminary report on treatment, safety and efficacy.Semantic proximity Read ↗

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.Semantic proximity Read ↗

Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.Semantic proximity Read ↗

Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.